Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Nucleoside drugs >  Nucleoside Intermediates >  5'-DMT-RIBO ADENOSINE (N-BZ)

5'-DMT-RIBO ADENOSINE (N-BZ)

Basic information Safety Supplier Related

5'-DMT-RIBO ADENOSINE (N-BZ) Basic information

Product Name:
5'-DMT-RIBO ADENOSINE (N-BZ)
Synonyms:
  • N6-Benzoyl-5'-O-DMT-adenosine
  • DTN-006 5'-O-(4,4'-DiMethoxytrityl)-N6-benzoyl-adenosine
  • 5'-DMT-Bz-rA
  • 5'-O-DMT-N6-Bz Adenosine
  • N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)adenosine
  • N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]adenosine
  • N6-Bz-DMT-Ar
  • 5'-O-dimethoxytrityl-N6-benzoyl adenosine
CAS:
81246-82-4
MF:
C38H35N5O7
MW:
673.71
EINECS:
2017-001-1
Mol File:
81246-82-4.mol
More
Less

5'-DMT-RIBO ADENOSINE (N-BZ) Chemical Properties

Density 
1.36
storage temp. 
Sealed in dry,2-8°C
form 
Solid
pka
7.87±0.43(Predicted)
color 
White to off-white
More
Less

Safety Information

HS Code 
2933599590
More
Less

5'-DMT-RIBO ADENOSINE (N-BZ) Usage And Synthesis

Uses

5'-O-DMT-Bz-rA is an intermediate for cyclic di-nucleotide compounds?synthesis[1].

Synthesis

40615-36-9

4546-55-8

129666-75-7

The general procedure for the synthesis of the target compound (CAS: 129666-75-7) from 4,4'-dimethoxytrityl chloride (DMTrCl) and N6-benzoyl adenosine was as follows: to a pyridine solution (100 g, 269.3 mmol, 0.5 mmol) containing N-(9-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl) at 0 °C, N-(9-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl )-benzamide (100 g, 269.3 mmol) to a pyridine solution (500 mL) was added DMAP (1.64 g, 13.46 mmol, 0.05 equiv) and DMTrCl (100.4 g, 296.2 mmol, 1.1 equiv) in sequence. The reaction mixture was stirred at room temperature for 16 h. Upon completion of the reaction, the reaction was quenched by addition of methanol (500 mL). Volatiles were removed by distillation under reduced pressure and the residue was purified by silica gel column chromatography (elution gradient: 1/1 petroleum ether/ethyl acetate to 100% ethyl acetate) to afford N-(9-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzene Formamide, as a white foamy solid (150 g, 223 mmol, 83% yield).

References

[1] Boyu Zhong, et al. Cyclic di-nucleotide compounds and methods of use. Patent WO2017161349.

5'-DMT-RIBO ADENOSINE (N-BZ)Supplier

Hongene Biotech Corporation
Tel
021-64757213
Email
info@hongene.com
Jia Xing Isenchem Co.,Ltd
Tel
0573-85285100 18627885956
Email
isenchem@163.com
Wuhu Huaren Science and Technology Co., Ltd.
Tel
0553-5842013-801 18155347026
Email
jinhuaren@huarensh.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
shanghai Rainbow MediTech.Co.Ltd.
Tel
021-64968085,64968086-5815,5812; 13472757003
Email
xiaoxia.zeng@rainbowpharma.cn